Beranda › Kanker Kandung Kemih
Uji klinis Kanker Kandung Kemih yang merekrut di AS
142 studi untuk Kanker Kandung Kemih merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY34 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Washington, DC26 studi
- Boston, MA26 studi
- Los Angeles, CA24 studi
- Baltimore, MD24 studi
- St. Louis, MO22 studi
- Edison, NJ22 studi
- Chicago, IL21 studi
- Seattle, WA21 studi
- Philadelphia, PA21 studi
- Durham, NC20 studi
- Columbus, OH19 studi
- Cleveland, OH18 studi
- Queens, NY16 studi
- Atlanta, GA15 studi
- Baldwin Park, CA14 studi
- San Francisco, CA13 studi
- Portland, OR13 studi
- San Antonio, TX13 studi
- Rochester, MN12 studi
- Austin, TX12 studi
- Grand Rapids, MI12 studi
- Orange, CA12 studi
- Kansas City, KS12 studi
- Detroit, MI11 studi
- Oklahoma City, OK11 studi
- Minneapolis, MN11 studi
- Staten Island, NY11 studi
- Milwaukee, WI11 studi
- New Rochelle, NY11 studi
- Denver, CO11 studi
- San Diego, CA11 studi
- Birmingham, AL11 studi
- Irvine, CA11 studi
- Salt Lake City, UT10 studi
- Jacksonville, FL10 studi
- Kansas City, MO10 studi
Berdasarkan negara bagian
- Alabama11 studi
- Alaska3 studi
- Arizona20 studi
- Arkansas15 studi
- California54 studi
- Colorado20 studi
- Connecticut10 studi
- Delaware4 studi
- Distrik Columbia17 studi
- Florida38 studi
- Georgia18 studi
- Idaho6 studi
- Illinois30 studi
- Indiana14 studi
- Iowa12 studi
- Kansas17 studi
- Kentucky7 studi
- Louisiana13 studi
- Maryland36 studi
- Massachusetts31 studi
- Michigan25 studi
- Minnesota24 studi
- Mississippi3 studi
- Missouri27 studi
- Montana7 studi
- Nebraska11 studi
- Nevada4 studi
- New Hampshire3 studi
- New Jersey26 studi
- New Mexico3 studi
- New York40 studi
- North Carolina26 studi
- North Dakota4 studi
- Ohio36 studi
- Oklahoma12 studi
- Oregon14 studi
- Pennsylvania27 studi
- Rhode Island4 studi
- South Carolina16 studi
- South Dakota4 studi
- Tennessee34 studi
- Texas51 studi
- Utah14 studi
- Vermont3 studi
- Virginia24 studi
- Washington25 studi
- West Virginia5 studi
- Wisconsin17 studi
- Wyoming4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06263153A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06470282Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07061964Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06764095A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07664397A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06833073The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382Patient-Centered Surgical Prehabilitation
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05715684Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07566156Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06394570Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07667335Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT00026884Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06770582DK222 Study at Hopkins
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07421700En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04235764A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07206225A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07419295DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07218380Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.